|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
|
US4920016A
(en)
|
1986-12-24 |
1990-04-24 |
Linear Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
EP0768377A1
(en)
|
1988-09-02 |
1997-04-16 |
Protein Engineering Corporation |
Generation and selection of recombinant varied binding proteins
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
CA2109602C
(en)
|
1990-07-10 |
2002-10-01 |
Gregory P. Winter |
Methods for producing members of specific binding pairs
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
AU8507191A
(en)
|
1990-08-29 |
1992-03-30 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
ES2113940T3
(es)
|
1990-12-03 |
1998-05-16 |
Genentech Inc |
Metodo de enriquecimiento para variantes de proteinas con propiedades de union alteradas.
|
|
DE69233769D1
(de)
|
1991-03-01 |
2009-09-24 |
Dyax Corp |
Chimäres Protein mit Mikroprotein mit zwei oder mehr Disulfidbindungen und Ausgestaltungen davon
|
|
AU662148B2
(en)
|
1991-04-10 |
1995-08-24 |
Scripps Research Institute, The |
Heterodimeric receptor libraries using phagemids
|
|
US5871907A
(en)
|
1991-05-15 |
1999-02-16 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
DE4122599C2
(de)
|
1991-07-08 |
1993-11-11 |
Deutsches Krebsforsch |
Phagemid zum Screenen von Antikörpern
|
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
|
US6214334B1
(en)
|
1991-10-21 |
2001-04-10 |
Trustees Of The University Of Pennsylvania |
Compositions and methods for producing and using homogenous neuronal cell transplants to treat neurodegenerative disorders and brain and spinal cord injuries
|
|
US5681747A
(en)
|
1992-03-16 |
1997-10-28 |
Isis Pharmaceuticals, Inc. |
Nucleic acid sequences encoding protein kinase C and antisense inhibition of expression thereof
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
AU687010B2
(en)
|
1992-07-17 |
1998-02-19 |
Dana-Farber Cancer Institute |
Method of intracellular binding of target molecules
|
|
DE4239877C1
(de)
|
1992-11-27 |
1994-03-17 |
Boehringer Ingelheim Int |
Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung
|
|
WO1995003832A1
(en)
|
1993-07-30 |
1995-02-09 |
Thomas Jefferson University |
Intracellular immunization
|
|
FR2721943B1
(fr)
|
1994-06-29 |
1996-08-02 |
Rhone Poulenc Rorer Sa |
Adenovirus comprenant un gene codant pour une superoxyde dismutase
|
|
US5556837A
(en)
|
1994-08-01 |
1996-09-17 |
Regeneron Pharmaceuticals Inc. |
Methods for treating addictive disorders
|
|
US5614649A
(en)
|
1994-11-14 |
1997-03-25 |
Cephalon, Inc. |
Multicatalytic protease inhibitors
|
|
US5783683A
(en)
|
1995-01-10 |
1998-07-21 |
Genta Inc. |
Antisense oligonucleotides which reduce expression of the FGFRI gene
|
|
US5853987A
(en)
|
1995-04-24 |
1998-12-29 |
The Texas A & M University System |
Decorin binding protein compositions and methods of use
|
|
US5834457A
(en)
|
1996-01-26 |
1998-11-10 |
The Regents Of The University Of California |
Method of modulating radical formation by mutant cuznsod enzymes
|
|
CA2284039A1
(en)
|
1997-03-18 |
1998-09-24 |
Ortho-Mcneil Pharmaceutical, Inc. |
Methods and kits for treating and diagnosing leiomyomas
|
|
US7863444B2
(en)
|
1997-03-19 |
2011-01-04 |
Abbott Laboratories |
4-aminopyrrolopyrimidines as kinase inhibitors
|
|
US6723694B1
(en)
|
1997-05-21 |
2004-04-20 |
The Children's Medical Center Corp. |
Short peptides which selectively modulate intracellular signalling
|
|
GB9718913D0
(en)
|
1997-09-05 |
1997-11-12 |
Glaxo Group Ltd |
Substituted oxindole derivatives
|
|
US6096778A
(en)
|
1997-10-07 |
2000-08-01 |
Cephalon, Inc. |
α-ketoamide multicatalytic protease inhibitors
|
|
US20010006793A1
(en)
|
1998-03-20 |
2001-07-05 |
Mary-Ann Bjornsti |
Modulators of eukaryotic caspases
|
|
ZA200007412B
(en)
|
1998-05-15 |
2002-03-12 |
Imclone Systems Inc |
Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases.
|
|
EP1087782A4
(en)
|
1998-06-15 |
2001-09-12 |
Neuronz Ltd |
REGULATION OF TYROSINE HYDROXYLASE
|
|
US6713474B2
(en)
|
1998-09-18 |
2004-03-30 |
Abbott Gmbh & Co. Kg |
Pyrrolopyrimidines as therapeutic agents
|
|
US6927044B2
(en)
|
1998-09-25 |
2005-08-09 |
Regeneron Pharmaceuticals, Inc. |
IL-1 receptor based cytokine traps
|
|
US6319905B1
(en)
|
1998-12-29 |
2001-11-20 |
Cell Genesys, Inc. |
Method of controlling L-Dopa production and of treating dopamine deficiency
|
|
US6841567B1
(en)
|
1999-02-12 |
2005-01-11 |
Cephalon, Inc. |
Cyclic substituted fused pyrrolocarbazoles and isoindolones
|
|
US6624171B1
(en)
|
1999-03-04 |
2003-09-23 |
Smithkline Beecham Corporation |
Substituted aza-oxindole derivatives
|
|
US6312949B1
(en)
|
1999-03-26 |
2001-11-06 |
The Salk Institute For Biological Studies |
Regulation of tyrosine hydroxylase expression
|
|
US6297238B1
(en)
|
1999-04-06 |
2001-10-02 |
Basf Aktiengesellschaft |
Therapeutic agents
|
|
US6982265B1
(en)
|
1999-05-21 |
2006-01-03 |
Bristol Myers Squibb Company |
Pyrrolotriazine inhibitors of kinases
|
|
US20030125276A1
(en)
|
2001-11-08 |
2003-07-03 |
Isis Pharmaceuticals Inc. |
Antisense modulation of thyroid hormone receptor interactor 6 expression
|
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
|
US6797720B2
(en)
|
1999-12-03 |
2004-09-28 |
Ono Pharmaceutical Co., Ltd. |
1,3,4-oxadiazoline derivative and an agent comprising its derivative as active ingredient
|
|
WO2001044214A1
(en)
|
1999-12-03 |
2001-06-21 |
Ono Pharmaceutical Co., Ltd. |
Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
|
|
US6334998B1
(en)
|
1999-12-07 |
2002-01-01 |
Parker Hughes Institute |
Estrogens for treating ALS
|
|
CA2395520A1
(en)
|
1999-12-21 |
2001-06-28 |
Sugen, Inc. |
4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
|
|
US7108984B2
(en)
|
2000-01-12 |
2006-09-19 |
Mount Sinai School Of Medicine |
Methods of identifying modulators of the FGF receptor
|
|
US20020081663A1
(en)
|
2000-01-05 |
2002-06-27 |
Conklin Darrell C. |
Novel FGF homolog ZFGF11
|
|
AU2001228810A1
(en)
|
2000-01-26 |
2001-08-07 |
Ono Pharmaceutical Co. Ltd. |
Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
|
|
JP2001292778A
(ja)
|
2000-04-11 |
2001-10-23 |
Inst Of Physical & Chemical Res |
トランケート型リーリンタンパク質およびそれをコードするｄｎａ
|
|
US6372250B1
(en)
|
2000-04-25 |
2002-04-16 |
The Regents Of The University Of California |
Non-invasive gene targeting to the brain
|
|
US20030211967A1
(en)
|
2001-05-07 |
2003-11-13 |
Bryant Henry Uhlman |
Method for selectively inhibiting ghrelin action
|
|
US6967237B2
(en)
|
2000-05-30 |
2005-11-22 |
Merck & Co., Inc. |
Ghrelin analogs
|
|
WO2002000853A2
(en)
|
2000-06-26 |
2002-01-03 |
Bayer Aktiengesellschaft |
Regulation of human caspase-1-like protease
|
|
JP2002017361A
(ja)
|
2000-07-04 |
2002-01-22 |
Inst Of Physical & Chemical Res |
リーリンタンパク質ｃｒ−５０エピトープ領域
|
|
JP4409135B2
(ja)
*
|
2000-12-01 |
2010-02-03 |
武田薬品工業株式会社 |
生理活性物質含有製剤の製造法
|
|
US7381701B2
(en)
|
2001-02-15 |
2008-06-03 |
The Borad Of Trustees Of The University Of Illinois |
Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
|
|
JPWO2002077226A1
(ja)
|
2001-03-23 |
2004-07-15 |
小野薬品工業株式会社 |
プロスタグランジンｅｐ１受容体
|
|
WO2002083131A1
(en)
|
2001-04-13 |
2002-10-24 |
The Regents Of The University Of California |
Activators and ligands of ppar-beta/delta for the treatment of skin conditions
|
|
AU2002256359A1
(en)
|
2001-04-24 |
2002-11-05 |
Epigenesis Pharmaceuticals, Inc. |
Antisense and anti-inflammatory based compositions to treat respiratory disorders
|
|
US20050182006A1
(en)
|
2001-05-18 |
2005-08-18 |
Sirna Therapeutics, Inc |
RNA interference mediated inhibition of protein kinase C alpha (PKC-alpha) gene expression using short interfering nucleic acid (siNA)
|
|
JPWO2002096892A1
(ja)
|
2001-05-31 |
2004-09-09 |
小野薬品工業株式会社 |
オキサジアゾール誘導体化合物およびその化合物を有効成分とする薬剤
|
|
US7736677B2
(en)
|
2001-06-20 |
2010-06-15 |
Metaproteomics, Llc |
Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment
|
|
AU2002315393A1
(en)
|
2001-06-21 |
2003-01-08 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of superoxide dismutase 1, soluble expression
|
|
CA2452578A1
(en)
|
2001-07-03 |
2003-01-16 |
The Hospital For Sick Children |
Ephrin and eph receptor mediated immune modulation
|
|
DE10134196B4
(de)
|
2001-07-13 |
2005-08-18 |
Forschungszentrum Karlsruhe Gmbh Technik Und Umwelt |
Pharmazeutische Zusammensetzung zur Hemmung der unkontrollierten Vermehrung und/oder Induzierung der Apoptose von Zellen
|
|
US7348140B1
(en)
|
2001-07-25 |
2008-03-25 |
Acadia Pharmaceuticals, Inc. |
Clinical indications for genotyping polymorphic variants of G-protein coupled receptors
|
|
DE60230877D1
(de)
|
2001-08-15 |
2009-03-05 |
Univ Brown Res Found |
Behandlung von muskeldystrophien und verwandter erkrankungen
|
|
WO2003016343A2
(en)
|
2001-08-16 |
2003-02-27 |
Angiogene Inc. |
USE OF αCP1, αCP2, AND HUR FOR MODULATING GENE EXPRESSION AND INDUCING ANGIOGENESIS
|
|
AU2002324937B2
(en)
|
2001-09-07 |
2008-11-13 |
The Trustees Of Boston Univeristy |
Method and composition for treating immune complex associated disorders
|
|
EP1451581A4
(en)
|
2001-10-05 |
2006-01-11 |
Coley Pharm Gmbh |
AGONISTS AND ANTAGONISTS OF THE SIGNALING OF THE GREAT-SIMILAR RECEPTOR 3
|
|
US20030078199A1
(en)
|
2001-10-09 |
2003-04-24 |
Youmin Shu |
Human EphA6 gene and polypeptide
|
|
JP4276074B2
(ja)
|
2001-10-12 |
2009-06-10 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤応答性受容体δの活性化剤
|
|
EP1442062A4
(en)
|
2001-10-18 |
2005-11-09 |
Genentech Inc |
METHOD FOR TREATING CARCINOMA
|
|
CA2464887A1
(en)
|
2001-10-30 |
2003-05-08 |
Biogen, Inc. |
Methods and compositions for treating parkinson's disease
|
|
KR100898894B1
(ko)
|
2001-11-05 |
2009-05-21 |
메르크 파텐트 게엠베하 |
히드라조노-말로니트릴
|
|
US20030165485A1
(en)
|
2001-11-09 |
2003-09-04 |
Goran Bertilsson |
Functional role and potential therapeutic use of Reelin, Gas6 and Protein S in relation to adult neural stem or progenitor cells
|
|
WO2003047511A2
(en)
|
2001-11-29 |
2003-06-12 |
U.S. Department Of Veterans Affairs |
Use of gingko biloba extracts to promote neuroprotection and reduce weight loss
|
|
CN102526045A
(zh)
|
2001-12-06 |
2012-07-04 |
法布罗根股份有限公司 |
提高内源性红细胞生成素(epo)的方法
|
|
CN1606451A
(zh)
|
2001-12-19 |
2005-04-13 |
伊藤火腿株式会社 |
构象病的治疗剂和/或预防剂
|
|
JP2005530687A
(ja)
|
2002-01-31 |
2005-10-13 |
マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ |
Ｆｇｆｒアゴニスト
|
|
US20030199525A1
(en)
|
2002-03-21 |
2003-10-23 |
Hirst Gavin C. |
Kinase inhibitors
|
|
US20030225098A1
(en)
|
2002-03-21 |
2003-12-04 |
Hirst Gavin C. |
Kinase inhibitors
|
|
SI1487541T1
(sl)
|
2002-03-22 |
2009-02-28 |
Serono Lab |
Uporaba inhibitorjev il-18 za zdravljenje in /alipreventivo bolezni perifernega oĺ˝ilja
|
|
AU2003227066A1
(en)
|
2002-03-26 |
2003-10-08 |
Bayer Aktiengesellschaft |
Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
|
|
IL149562A0
(en)
|
2002-05-09 |
2002-11-10 |
Prochon Ltd |
Fgf variants and methods for use thereof
|
|
ES2615484T3
(es)
|
2002-05-21 |
2017-06-07 |
Daiichi Sankyo Company, Limited |
Composiciones medicinales que contienen grelina
|
|
AU2003238948A1
(en)
|
2002-06-05 |
2003-12-22 |
Sunesis Pharmaceuticals, Inc. |
Caspase-1 inhibitors and methods for their use
|
|
US20040022765A1
(en)
|
2002-07-31 |
2004-02-05 |
Isis Pharmaceuticals Inc. |
Antisense modulation of Ran GTPase activating protein 1 expression
|
|
AU2003246261A1
(en)
|
2002-07-05 |
2004-01-23 |
Chugai Seiyaku Kabushiki Kaisha |
Remedy for diabetes
|
|
TWI329112B
(en)
|
2002-07-19 |
2010-08-21 |
Bristol Myers Squibb Co |
Novel inhibitors of kinases
|
|
EP1530635B1
(en)
*
|
2002-08-01 |
2011-06-15 |
Noxxon Pharma AG |
Ghrelin binding nucleic acids
|
|
WO2004013145A1
(en)
|
2002-08-02 |
2004-02-12 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
|
DE10244453A1
(de)
|
2002-09-24 |
2004-04-01 |
Phenomiques Gmbh |
Hemmung der Proteinkinase C-alpha zur Behandlung von Krankheiten
|
|
EP1407760A1
(de)
|
2002-10-08 |
2004-04-14 |
Cognis France S.A. |
Verfahren zum Schutz der Haut gegen Alterung
|
|
EP1558640B1
(en)
|
2002-10-29 |
2011-04-13 |
Anaphore, Inc. |
Trimeric binding proteins for trimeric cytokines
|
|
ATE443764T1
(de)
|
2002-11-04 |
2009-10-15 |
Univ Massachusetts |
Allelspezifische rna-interferenz
|
|
JP2006507841A
(ja)
|
2002-11-14 |
2006-03-09 |
ダーマコン， インコーポレイテッド |
機能的ｓｉＲＮＡおよび超機能的ｓｉＲＮＡ
|
|
JP3810731B2
(ja)
|
2002-11-29 |
2006-08-16 |
独立行政法人科学技術振興機構 |
哺乳動物のＴｏｌｌ様受容体３に結合する新規アダプタータンパク質およびその遺伝子
|
|
US8124582B2
(en)
|
2002-12-06 |
2012-02-28 |
Fibrogen, Inc. |
Treatment of diabetes
|
|
ATE545429T1
(de)
|
2002-12-20 |
2012-03-15 |
Lundbeck & Co As H |
Modulation der neurotrophinaktivität;screeningsverfahren
|
|
WO2004064713A2
(en)
|
2003-01-20 |
2004-08-05 |
Vib Vzw |
The use of yop preoteins or rho gtpase inhibitors as caspase-1 inhibitors
|
|
US7354933B2
(en)
|
2003-01-31 |
2008-04-08 |
Aventis Pharma Sa |
Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
|
|
CN101444621B
(zh)
|
2003-02-11 |
2013-11-20 |
夏尔人类遗传性治疗公司 |
使用甲酰-甘氨酸生成酶(fge)对多种硫酸酯酶缺乏症和其它病症进行诊断和治疗
|
|
US20040220270A1
(en)
|
2003-03-07 |
2004-11-04 |
The Jackson Laboratory |
Methods and composition of treating glaucoma by modulating tyrosinase/L-DOPA pathway
|
|
CA2522441A1
(en)
|
2003-03-27 |
2004-10-14 |
Emory University |
Hif-1 inhibitors
|
|
US7253166B2
(en)
|
2003-04-22 |
2007-08-07 |
Irm Llc |
6-phenyl-7H-pyrrolo[2,3-d]pyrimidine compounds that induce neuronal differentiation in embryonic stem cells
|
|
US20040242559A1
(en)
|
2003-04-25 |
2004-12-02 |
Aventis Pharma S.A. |
Novel indole derivatives, preparation thereof as medicinal products and pharmaceutical compositions, and especially as KDR inhibitors
|
|
US20050043233A1
(en)
|
2003-04-29 |
2005-02-24 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
|
|
ES2383685T3
(es)
|
2003-04-30 |
2012-06-25 |
Kenji Kangawa |
Preventivos o remedios para hepatopatía
|
|
US7423031B2
(en)
|
2003-05-01 |
2008-09-09 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
|
ME00541B
(me)
|
2003-05-23 |
2011-10-10 |
Zentaris Gmbh |
NOVI PIRIDOPIRAZINI I NJlUHOVA UPOTREBA KAO MODULATORA KlNAZA
|
|
US7476653B2
(en)
|
2003-06-18 |
2009-01-13 |
Tranzyme Pharma, Inc. |
Macrocyclic modulators of the ghrelin receptor
|
|
US20050002897A1
(en)
|
2003-06-18 |
2005-01-06 |
Ulrich Haupts |
Biological entities and the pharmaceutical or diagnostic use thereof
|
|
JP2007524615A
(ja)
|
2003-06-20 |
2007-08-30 |
コーリー ファーマシューティカル ゲーエムベーハー |
低分子トール様レセプター（ｔｌｒ）アンタゴニスト
|
|
US8592391B2
(en)
|
2003-07-01 |
2013-11-26 |
Andres Salazar |
Method for therapeutic, clinical and veterinary use poly-ICLC
|
|
US7276608B2
(en)
|
2003-07-11 |
2007-10-02 |
Bristol-Myers Squibb Company |
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
|
|
DE602004027508D1
(de)
|
2003-08-07 |
2010-07-15 |
Enkam Pharmaceuticals As |
Lpa-haltige verbindungen
|
|
EP2060270A3
(en)
|
2003-10-16 |
2009-12-09 |
Imclone LLC |
Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof
|
|
US20080248462A1
(en)
|
2003-10-21 |
2008-10-09 |
Baayer Healhcare Ag |
Diagnostics and Therapeutics for Diseases Associated with Arginyl Aminopeptidase (Aminopeptidase B)-Like 1 (Rnpepl1)
|
|
GB0325031D0
(en)
|
2003-10-27 |
2003-12-03 |
Novartis Ag |
Organic compounds
|
|
CA2544602A1
(en)
|
2003-11-04 |
2005-05-26 |
Elixir Pharmaceuticals, Inc. |
Therapeutic compounds and uses thereof
|
|
CA2543315A1
(en)
|
2003-11-13 |
2005-06-02 |
The General Hospital Corporation |
Methods for treating pain
|
|
WO2005048916A2
(en)
|
2003-11-20 |
2005-06-02 |
Biovitrum Ab |
Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders
|
|
EP1693070A1
(en)
|
2003-11-26 |
2006-08-23 |
Daiichi Pharmaceutical Co., Ltd. |
Procaspase 1 activation inhibitor
|
|
JP2007513967A
(ja)
|
2003-12-11 |
2007-05-31 |
セラヴァンス， インコーポレーテッド |
変異レセプターチロシンキナーゼが駆動する細胞増殖性疾患の処置において使用するための組成物
|
|
HRP20070241T3
(hr)
|
2003-12-19 |
2007-07-31 |
Bristol-Myers Squibb Company |
Azabiciklički heterocikli kao modulatori kanabinoid receptora
|
|
WO2005066211A2
(en)
|
2003-12-19 |
2005-07-21 |
Five Prime Therapeutics, Inc. |
Fibroblast growth factor receptors 1, 2, 3, and 4 as targets for therapeutic intervention
|
|
EP1704228B1
(en)
|
2004-01-16 |
2012-04-11 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Immunokinases
|
|
US20050222171A1
(en)
|
2004-01-22 |
2005-10-06 |
Guido Bold |
Organic compounds
|
|
WO2005074923A1
(en)
|
2004-02-03 |
2005-08-18 |
Agt Biosciences Limited |
Methods and compositions
|
|
EP1720567A2
(en)
|
2004-02-10 |
2006-11-15 |
Innate Pharma |
Composition and method for the treatment of carcinoma
|
|
EP1742961A4
(en)
|
2004-02-13 |
2009-07-15 |
Boston Biomedical Res Inst |
LOCKING OF FGF SIGNALING
|
|
US20060058255A1
(en)
|
2004-03-01 |
2006-03-16 |
Jianzhu Chen |
RNAi-based therapeutics for allergic rhinitis and asthma
|
|
US20060211752A1
(en)
|
2004-03-16 |
2006-09-21 |
Kohn Leonard D |
Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
|
|
EP1730520A2
(en)
|
2004-03-24 |
2006-12-13 |
Bayer HealthCare AG |
Diagnostics and therapeutics for diseases associated with peroxisome proliferator activated receptor delta (ppard)
|
|
FR2868422B1
(fr)
|
2004-03-31 |
2006-07-14 |
Aventis Pharma Sa |
Nouveaux derives pyrrolo(2,3-b) pyridine, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
|
JP2007530703A
(ja)
|
2004-04-01 |
2007-11-01 |
アベンティス・ファーマスーティカルズ・インコーポレイテツド |
Ｍｓおよびその他の脱髄疾患を治療するためのペルオキシソーム増殖因子活性化受容体デルタアゴニストの使用
|
|
BRPI0508180A
(pt)
|
2004-04-01 |
2007-08-07 |
Aventis Pharma Inc |
1,3,4-oxadiazol-2-onas como moduladores de ppar delta e seu uso deste
|
|
US7498316B2
(en)
|
2004-04-06 |
2009-03-03 |
University Of Massachusetts |
Methods and compositions for treating gain-of-function disorders using RNA interference
|
|
WO2005099741A1
(ja)
|
2004-04-08 |
2005-10-27 |
Noevir Co., Ltd. |
運動ニューロン疾患治療薬
|
|
US7838645B2
(en)
*
|
2004-04-30 |
2010-11-23 |
University Of Maryland College Park |
Function of autophagy genes in cell death
|
|
US7357933B2
(en)
|
2004-05-05 |
2008-04-15 |
Enhan Technology Holdings International Co., Ltd. |
Sporoderm-broken germination-activated ganoderma lucidum spores for protection of dopaminergic neurons and treatment of Parkinson's disease
|
|
AU2005245896A1
(en)
|
2004-05-14 |
2005-12-01 |
Receptor Biologix, Inc. |
Cell surface receptor isoforms and methods of identifying and using the same
|
|
CA2566362C
(en)
|
2004-05-15 |
2013-09-10 |
Vertex Pharmaceuticals Incorporated |
Treating seizures using ice inhibitors
|
|
GB0411791D0
(en)
|
2004-05-26 |
2004-06-30 |
Cyclacel Ltd |
Compounds
|
|
WO2005118587A1
(en)
|
2004-06-02 |
2005-12-15 |
Takeda Pharmaceutical Company Limited |
Indole derivative and use for treatment of cancer
|
|
WO2005120570A2
(en)
|
2004-06-03 |
2005-12-22 |
The University Of Maryland, Baltimore |
Therapeutic targeting of parc/ccl18 and its signaling in pulmonary fibrosis
|
|
AU2005249570B2
(en)
|
2004-06-04 |
2011-06-16 |
Regeneron Pharmaceuticals, Inc. |
Methods of using IL-1 antagonists to treat autoinflammatory disease
|
|
US7102002B2
(en)
|
2004-06-16 |
2006-09-05 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
|
BRPI0512254A
(pt)
|
2004-06-18 |
2008-02-19 |
Enkam Pharmaceuticals As |
peptìdeos ligantes ao fgfr
|
|
WO2006014653A1
(en)
|
2004-07-20 |
2006-02-09 |
Schering Corporation |
Induction of apoptosis in toll-like receptor expressing tumor cells
|
|
EP1621539A1
(en)
|
2004-07-27 |
2006-02-01 |
Aventis Pharma S.A. |
Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
|
|
EP1621536A1
(en)
|
2004-07-27 |
2006-02-01 |
Aventis Pharma S.A. |
Amino cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
|
|
EP1621535A1
(en)
|
2004-07-27 |
2006-02-01 |
Aventis Pharma S.A. |
Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
|
|
CA2577060A1
(en)
|
2004-08-13 |
2006-02-23 |
Amgen Inc. |
Substituted benzofused heterocycles
|
|
AU2005277641A1
(en)
|
2004-08-16 |
2006-03-02 |
Medimmune, Llc |
Eph receptor Fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity
|
|
EP1800131A2
(en)
|
2004-09-09 |
2007-06-27 |
Bayer HealthCare AG |
Diagnostics and therapeutics for diseases associated with adrenomedullin receptor (amdr)
|
|
ES2614113T3
(es)
|
2004-09-17 |
2017-05-29 |
Biomas Ltd. |
Uso de tricloro (dioxietilen-O,O) telurato de amonio (AS101) para la inhibición de la enzima convertidora de interleucina-1 beta
|
|
FR2876103B1
(fr)
|
2004-10-01 |
2008-02-22 |
Aventis Pharma Sa |
Nouveaux derives bis-azaindoles, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
|
WO2006047639A2
(en)
|
2004-10-27 |
2006-05-04 |
Medimmune, Inc. |
Modulation of antibody specificity by tailoring the affinity to cognate antigens
|
|
CA2586080A1
(en)
|
2004-11-01 |
2006-08-31 |
University Of Southern California |
Novel compounds for treatment of cancer and disorders associated with angiogenesis function
|
|
CA2587676A1
(en)
|
2004-11-19 |
2006-05-26 |
Institut Gustave Roussy |
Improved treatment of cancer by double-stranded rna
|
|
EP1662259A1
(en)
|
2004-11-25 |
2006-05-31 |
Cellzome Ag |
Use of Eph receptor inhibitors for the treatment of neurodegenerative diseases
|
|
AR051836A1
(es)
|
2004-11-30 |
2007-02-14 |
Centocor Inc |
Antagonistas de receptor 3 simil toll metodos y usos
|
|
JP2008521840A
(ja)
|
2004-11-30 |
2008-06-26 |
ガストロテック・ファルマ・アクティーゼルスカブ |
成長ホルモン分泌促進物質レセプター１ａリガンド
|
|
AU2005323173A1
(en)
|
2004-12-01 |
2006-07-13 |
The Curators Of The University Of Missouri |
Modulator of alpha-synuclein toxicity
|
|
DE602005023345D1
(de)
|
2004-12-17 |
2010-10-14 |
Beth Israel Hospital |
Zusammensetzungen für bakteriell vermitteltes gen-silencing sowie verfahren zur verwendung davon
|
|
US7834064B2
(en)
|
2005-01-03 |
2010-11-16 |
Andres Mario Salazar |
Clinical method for the immunomodulatory and vaccine adjuvant use of poly-ICLC and other dsRNAs
|
|
CA2593648A1
(en)
|
2005-01-10 |
2006-07-13 |
Research Development Foundation |
Targeted chimeric molecules for cancer therapy
|
|
US20060160737A1
(en)
|
2005-01-14 |
2006-07-20 |
Allen Radin |
Methods of using IL-1 antagonists to treat polymyalgia rheumatica and giant cell arteritis
|
|
US20060194821A1
(en)
|
2005-02-18 |
2006-08-31 |
The Brigham And Women's Hospital, Inc. |
Compounds inhibiting the aggregation of superoxide dismutase-1
|
|
JP2008531502A
(ja)
|
2005-02-22 |
2008-08-14 |
ザ レジェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
胃腸の炎症を処置する方法
|
|
WO2006094124A2
(en)
|
2005-03-02 |
2006-09-08 |
The Scripps Research Institute |
Compositions and methods for treatment of autoimmune and related diseases
|
|
WO2006108270A1
(en)
|
2005-04-11 |
2006-10-19 |
Pharmagap Inc. |
Inhibitors of protein kinases and uses thereof
|
|
WO2006122931A1
(en)
|
2005-05-20 |
2006-11-23 |
Biovitrum Ab (Publ) |
Beta-carboline derivatives and theri use as ghsr modulators
|
|
EP1885181A2
(en)
|
2005-05-23 |
2008-02-13 |
Smithkline Beecham Corporation |
Inhibition of p38 mark for treatment of obesity
|
|
EP1924294A4
(en)
|
2005-05-24 |
2010-11-03 |
Isis Pharmaceuticals Inc |
COMPOSITIONS AND ITS USES AGAINST PTPRU
|
|
BRPI0613515A2
(pt)
|
2005-07-11 |
2011-01-11 |
Cbio Ltd |
imunomodulação induzida por chaperonina 10
|
|
GB0515026D0
(en)
|
2005-07-21 |
2005-08-31 |
Novartis Ag |
Organic compounds
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
EP1937827B1
(en)
|
2005-08-31 |
2011-09-28 |
Université Laval |
Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities
|
|
JP5329961B2
(ja)
|
2005-09-06 |
2013-10-30 |
トリニティー セラピューティクス インコーポレイテッド |
免疫介在性神経疾患を治療するための方法
|
|
FR2891273B1
(fr)
|
2005-09-27 |
2007-11-23 |
Aventis Pharma Sa |
NOUVEAUX DERIVES BENZIMIDAZOLES ET BENZOTHIAZOLES, LEUR PREPARATION ET LEUR UTILISATION PHARMACEUTIQUE NOTAMMENT COMME INHIBITEURS DE CMet
|
|
BRPI0616476A2
(pt)
|
2005-09-30 |
2011-06-21 |
Scynexis Inc |
uso de uma quantidade terapeuticamente eficaz de um derivado de ciclosporina, e, composição farmacêutica
|
|
US7598273B2
(en)
|
2005-10-06 |
2009-10-06 |
Auspex Pharmaceuticals, Inc |
Inhibitors of the gastric H+, K+-ATPase with enhanced therapeutic properties
|
|
CN101287742B
(zh)
|
2005-10-12 |
2016-01-06 |
艾德拉药物股份有限公司 |
基于变异应答调制Toll样受体的免疫调节寡核苷酸(IRO)化合物
|
|
KR20080075505A
(ko)
|
2005-10-20 |
2008-08-18 |
씨바이오 리미티드 |
과민증의 치료 방법
|
|
RU2008119687A
(ru)
|
2005-10-21 |
2009-11-27 |
Новартис АГ (CH) |
Комбинации органических соединений
|
|
JP5199878B2
(ja)
|
2005-10-27 |
2013-05-15 |
セントカー・インコーポレーテツド |
Ｔｏｌｌ様受容体３モジュレーター、方法および用途
|
|
ATE530562T1
(de)
|
2005-10-28 |
2011-11-15 |
Janssen Biotech Inc |
Tlr3-glycosylierungsstandortmuteine und verwendungsverfahren dafür
|
|
WO2007058998A2
(en)
|
2005-11-14 |
2007-05-24 |
Auspex Pharmaceuticals, Inc. |
Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
|
|
WO2007062119A1
(en)
|
2005-11-23 |
2007-05-31 |
Auspex Pharmaceuticals, Inc. |
Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity
|
|
PT1954669E
(pt)
|
2005-12-01 |
2015-10-23 |
Auspex Pharmaceuticals Inc |
Feniletilaminas substituídas com actividade serotoninérgica e/ou norepinefrinérgica
|
|
WO2007087451A2
(en)
|
2006-01-25 |
2007-08-02 |
University Of Massachusetts |
Compositions and methods for enhancing discriminatory rna interference
|
|
CA2638906A1
(en)
|
2006-01-26 |
2007-08-16 |
University Of Massachusetts |
Rna interference agents for therapeutic use
|
|
WO2007090068A2
(en)
|
2006-01-27 |
2007-08-09 |
Fibrogen, Inc. |
Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif)
|
|
AU2007215247B2
(en)
|
2006-02-10 |
2012-12-13 |
Transtech Pharma, Llc |
Benzazole derivatives, compositions, and methods of use as Aurora kinase inhibitors
|
|
EP1986657A4
(en)
|
2006-02-16 |
2011-07-20 |
Discogen Llc |
METHOD OF TREATING A SUBJECT SUFFERING FROM DEGENERATIVE DISCOPATHY BY A MATRIX METALLOPROTEASE INHIBITOR
|
|
WO2007103048A2
(en)
|
2006-03-01 |
2007-09-13 |
Regents Of The University Of Colorado |
Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity
|
|
EP1834953A1
(en)
|
2006-03-14 |
2007-09-19 |
Ranbaxy Laboratories Limited |
Tetrahydropyrane derivatives as 5-lipoxygenase inhibitors
|
|
JP5336349B2
(ja)
*
|
2006-03-15 |
2013-11-06 |
マイケル・オー・ソーナー |
成長ホルモン分泌促進物質による筋肉減少症の処置方法
|
|
US20070232556A1
(en)
|
2006-03-31 |
2007-10-04 |
Montine Thomas J |
Methods and compositions for the treatment of neurological diseases and disorders
|
|
EP2016078B1
(en)
|
2006-04-04 |
2016-06-15 |
Fibrogen, Inc. |
Pyrrolo- and thiazolo-pyridine compounds as hif modulators
|
|
US20070249519A1
(en)
|
2006-04-20 |
2007-10-25 |
Kalypsys, Inc. |
Methods for the upregulation of glut4 via modulation of ppar delta in adipose tissue and for the treatment of disease
|
|
US8536120B2
(en)
|
2006-04-28 |
2013-09-17 |
The Administrators Of The Tulane Educational Fund |
Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof
|
|
EP2023721A2
(en)
|
2006-06-05 |
2009-02-18 |
Auspex Pharmaceuticals Inc. |
Preparation and utility of substituted erythromycin analogs
|
|
EP2024365A4
(en)
|
2006-06-05 |
2010-08-25 |
Auspex Pharmaceuticals Inc |
PREPARATION AND UTILITY OF SUBSTITUTED IMIDAZOPYRIDINE COMPOUNDS HAVING HYPNOTIC EFFECTS
|
|
US20070287734A1
(en)
|
2006-06-09 |
2007-12-13 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted pyrazole compounds with cannabinoid receptor activity
|
|
EP2054392A2
(en)
|
2006-06-15 |
2009-05-06 |
Boehringer Ingelheim International GmbH |
2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha
|
|
KR20090023698A
(ko)
|
2006-06-15 |
2009-03-05 |
베링거 인겔하임 인터내셔날 게엠베하 |
2-아닐리노-4-아미노알킬렌아미노피리미딘
|
|
TW200817023A
(en)
|
2006-06-20 |
2008-04-16 |
Metaproteomics Llc |
Xanthohumol based protein kinase modulation cancer treatment
|
|
US8088733B2
(en)
|
2006-07-06 |
2012-01-03 |
Tranzyme Pharma Inc. |
Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders
|
|
US7585865B2
(en)
|
2006-07-21 |
2009-09-08 |
The Penn State Research Foundation |
Protein kinase C zeta inhibition to treat vascular permeability
|
|
WO2008016677A2
(en)
|
2006-08-02 |
2008-02-07 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of deuterated amphetamines
|
|
AU2007286186A1
(en)
|
2006-08-08 |
2008-02-21 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects
|
|
US8063225B2
(en)
|
2006-08-14 |
2011-11-22 |
Chembridge Corporation |
Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
|
|
CA2661302A1
(en)
|
2006-08-16 |
2008-02-21 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of opioid analgesics
|
|
WO2008026946A2
(en)
|
2006-08-30 |
2008-03-06 |
Genesis Research And Development Corporation Limited |
Compositions and methods for the treatment and prevention of neoplastic disorders
|
|
US20090074711A1
(en)
|
2006-09-07 |
2009-03-19 |
University Of Southhampton |
Human therapies using chimeric agonistic anti-human cd40 antibody
|
|
US20080221132A1
(en)
|
2006-09-11 |
2008-09-11 |
Xiong Cai |
Multi-Functional Small Molecules as Anti-Proliferative Agents
|
|
BRPI0715579A2
(pt)
|
2006-10-19 |
2015-05-26 |
Auspex Pharmaceuticals Inc |
"composto, composição farmacêutica e uso de um composto"
|
|
US9375440B2
(en)
|
2006-11-03 |
2016-06-28 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
|
US20080132555A1
(en)
|
2006-11-28 |
2008-06-05 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted phenyltetrazoles
|
|
US20080146573A1
(en)
|
2006-12-04 |
2008-06-19 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted oxzolidinones
|
|
US20080167312A1
(en)
|
2006-12-08 |
2008-07-10 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted allylamines
|
|
CA2677399C
(en)
|
2007-02-09 |
2016-09-13 |
Tranzyme Pharma, Inc. |
Macrocyclic ghrelin receptor modulators and methods of using the same
|
|
WO2008103899A1
(en)
|
2007-02-23 |
2008-08-28 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of non-nucleoside reverse transcriptase inhibitors
|
|
ES2693948T3
(es)
|
2007-03-15 |
2018-12-14 |
Auspex Pharmaceuticals, Inc. |
Fenetilamina sustituida con actividad serotoninérgica y/o norepinefrinérgica
|
|
WO2008113100A1
(en)
*
|
2007-03-16 |
2008-09-25 |
Novogen Research Pty Ltd |
Method for inducing autophagy
|
|
WO2008122020A1
(en)
|
2007-04-02 |
2008-10-09 |
Auspex Pharmaceuticals, Inc. |
Substituted pyrimidines
|
|
US7863308B2
(en)
|
2007-04-10 |
2011-01-04 |
Auspex Pharmaceuticals, Inc. |
Substituted thiophenes
|
|
WO2008130863A2
(en)
|
2007-04-11 |
2008-10-30 |
Auspex Pharmaceuticals, Inc. |
Substituted benzimidazoles
|
|
US20080262086A1
(en)
|
2007-04-18 |
2008-10-23 |
Auspex Pharmaceuticals, Inc. |
Substituted anthranilic acids
|
|
CN101765582A
(zh)
|
2007-04-26 |
2010-06-30 |
奥斯拜客斯制药有限公司 |
氘标记的氯胺酮
|
|
US20080280991A1
(en)
|
2007-05-08 |
2008-11-13 |
Auspex Pharmaceuticals, Inc. |
Substituted naphthalenes
|
|
US20080280886A1
(en)
|
2007-05-08 |
2008-11-13 |
Auspex Pharmaceuticals, Inc. |
Substituted ureas
|
|
WO2008143835A1
(en)
*
|
2007-05-15 |
2008-11-27 |
Yale University |
Ghrelin protects substantia nigra dopamine neurons
|
|
US20090005309A1
(en)
|
2007-05-18 |
2009-01-01 |
Auspex Pharmaceuticals, Inc. |
Substituted piperidines
|
|
WO2008147956A2
(en)
|
2007-05-25 |
2008-12-04 |
Centocor, Inc. |
Toll-like receptor 3 modulators and uses thereof
|
|
US7745665B2
(en)
|
2007-06-04 |
2010-06-29 |
Auspex Pharmaceuticals, Inc. |
Substituted phenethylamines
|
|
AU2008262291A1
(en)
|
2007-06-11 |
2008-12-18 |
Miikana Therapeutics, Inc. |
Substituted pyrazole compounds
|
|
US20080312247A1
(en)
|
2007-06-13 |
2008-12-18 |
Auspex Pharmaceuticals, Inc. |
Substituted piperazines
|
|
WO2008152816A1
(en)
*
|
2007-06-14 |
2008-12-18 |
Oncotherapy Science, Inc. |
Methods of identifying agents that modulate methylation of vegfr1 by smyd3
|
|
CA2691379C
(en)
|
2007-06-20 |
2015-06-09 |
Auspex Pharmaceuticals, Inc. |
Substituted n-aryl pyridinones
|
|
WO2009006413A1
(en)
|
2007-06-30 |
2009-01-08 |
Auspex Pharmaceuticals, Inc. |
Substituted pyrrolidines
|
|
US20090011994A1
(en)
|
2007-07-06 |
2009-01-08 |
Bristol-Myers Squibb Company |
Non-basic melanin concentrating hormone receptor-1 antagonists and methods
|
|
EP2193140B1
(en)
|
2007-08-27 |
2016-11-02 |
1Globe Health Institute LLC |
Compositions of asymmetric interfering rna and uses thereof
|
|
US7767860B2
(en)
|
2007-09-06 |
2010-08-03 |
Auspex Pharmaceuticals, Inc |
Substituted amino alcohols
|
|
US20090088401A1
(en)
|
2007-09-27 |
2009-04-02 |
Andres Salazar |
In-situ cancer autovaccination with intratumoral stabilized dsRNA viral mimic
|